FibroBiologics Inc. Commo...
1.98
0.10 (5.32%)
At close: Jan 15, 2025, 3:59 PM
2.02
2.02%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -16.48M -5.12M -1.58M -1.17M
Depreciation & Amortization 437.00K 94.00K n/a n/a
Stock-Based Compensation 1.76M 265.00K n/a n/a
Other Working Capital 352.00K 307.00K 172.00K n/a
Other Non-Cash Items 7.39M 842.00K n/a n/a
Deferred Income Tax n/a n/a n/a n/a
Change in Working Capital 493.00K 307.00K 172.00K n/a
Operating Cash Flow -6.40M -4.07M -1.41M -1.17M
Capital Expenditures -495.00K n/a n/a n/a
Acquisitions n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a
Investing Cash Flow -495.00K n/a n/a n/a
Debt Repayment n/a 3.77M 1.52M n/a
Common Stock Repurchased n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies 13.79M 4.30M 292.00K 1.17M
Financial Cash Flow 13.79M 5.92M 1.82M 1.17M
Net Cash Flow 6.90M 1.86M 407.00K n/a
Free Cash Flow -6.90M -4.07M -1.41M -1.17M